Outlook Therapeutics, Inc. (OTLK)
0.5898
+0.19
(+47.38%)
USD |
NASDAQ |
May 27, 16:00
0.58
-0.01
(-1.66%)
After-Hours: 16:47
Outlook Therapeutics Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| XOMA Royalty Corp. | 6.552M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| Amgen, Inc. | -716.00M |
| Savara, Inc. | 38.78M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.828M |
| Cash from Financing (Quarterly) | 6.899M |
| Free Cash Flow | -51.25M |
| Free Cash Flow Per Share (Quarterly) | -0.0957 |
| Free Cash Flow to Equity (Quarterly) | 1.877M |
| Free Cash Flow to Firm (Quarterly) | -7.828M |
| Free Cash Flow Yield | -165.6% |